ICU MEDICAL INC/DE Depreciation
ICU MEDICAL INC/DE (ICUI) reported Depreciation of $16.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- ICU MEDICAL INC/DE depreciation for the quarter ending 2026-06-30 was $16.60M, a 1.78% decline year-over-year.
- ICU MEDICAL INC/DE depreciation for the quarter ending 2026-03-31 was $16.90M, a 0.00% change year-over-year.
- ICU MEDICAL INC/DE depreciation for the quarter ending 2025-12-31 was $17.80M, a 7.29% decline year-over-year.
- ICU MEDICAL INC/DE depreciation for the quarter ending 2025-09-30 was $17.70M, a 17.29% decline year-over-year.
- ICU MEDICAL INC/DE depreciation for fiscal 2025 was $69.30M, a 18.66% decline from fiscal 2024.
- ICU MEDICAL INC/DE depreciation for fiscal 2024 was $85.20M, a 11.89% decline from fiscal 2023.
- ICU MEDICAL INC/DE depreciation for fiscal 2023 was $96.70M, a 0.94% increase from fiscal 2022.
- ICU MEDICAL INC/DE depreciation for fiscal 2022 was $95.80M, a 45.37% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.60M 10-Q · filed 2026-08-06 | $33.60M 10-Q · filed 2026-08-06 | $51.30M derived: sum of 3 quarters · filed 2026-08-06 | $69.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $16.90M 10-Q · filed 2026-05-07 | $34.70M derived: sum of 2 quarters · filed 2026-05-07 | $52.40M derived: sum of 3 quarters · filed 2026-05-07 | $69.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $17.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $35.50M derived: sum of 2 quarters · filed 2026-02-19 | $52.40M derived: sum of 3 quarters · filed 2026-08-06 | $69.30M 10-K · filed 2026-02-19 |
| 2025-09-30 | $17.70M 10-Q · filed 2025-11-06 | $34.60M derived: sum of 2 quarters · filed 2026-08-06 | $51.50M 10-Q · filed 2025-11-06 | $70.70M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $16.90M 10-Q · filed 2026-08-06 | $33.80M 10-Q · filed 2026-08-06 | $53.00M derived: sum of 3 quarters · filed 2026-08-06 | $74.40M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $16.90M 10-Q · filed 2025-05-08 | $36.10M derived: sum of 2 quarters · filed 2026-02-19 | $57.50M derived: sum of 3 quarters · filed 2026-02-19 | $79.80M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-12-31 | $19.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $40.60M derived: sum of 2 quarters · filed 2026-02-19 | $62.90M derived: sum of 3 quarters · filed 2026-02-19 | $85.20M 10-K · filed 2026-02-19 |
| 2024-09-30 | $21.40M 10-Q · filed 2025-11-06 | $43.70M derived: sum of 2 quarters · filed 2025-11-06 | $66.00M 10-Q · filed 2025-11-06 | $90.00M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $22.30M 10-Q · filed 2025-08-07 | $44.70M 10-Q · filed 2025-08-07 | $68.60M derived: sum of 3 quarters · filed 2026-02-19 | $93.60M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $22.40M 10-Q · filed 2025-05-08 | $46.30M derived: sum of 2 quarters · filed 2026-02-19 | $71.30M derived: sum of 3 quarters · filed 2026-02-19 | $95.70M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $23.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $48.90M derived: sum of 2 quarters · filed 2026-02-19 | $73.30M derived: sum of 3 quarters · filed 2026-02-19 | $96.70M 10-K · filed 2026-02-19 |
| 2023-09-30 | $25.00M 10-Q · filed 2024-11-12 | $49.40M derived: sum of 2 quarters · filed 2024-11-12 | $72.80M 10-Q · filed 2024-11-12 | $99.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $24.40M 10-Q · filed 2024-08-07 | $47.80M 10-Q · filed 2024-08-07 | $74.20M derived: sum of 3 quarters · filed 2025-02-27 | $97.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $23.40M 10-Q · filed 2024-05-07 | $49.80M derived: sum of 2 quarters · filed 2025-02-27 | $72.80M derived: sum of 3 quarters · filed 2025-02-27 | $97.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $26.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $49.40M derived: sum of 2 quarters · filed 2025-02-27 | $74.30M derived: sum of 3 quarters · filed 2025-02-27 | $95.80M 10-K · filed 2025-02-27 |
| 2022-09-30 | $23.00M 10-Q · filed 2023-11-06 | $47.90M derived: sum of 2 quarters · filed 2023-11-06 | $69.40M 10-Q · filed 2023-11-06 | $86.10M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $24.90M 10-Q · filed 2023-08-07 | $46.40M 10-Q · filed 2023-08-07 | $63.10M derived: sum of 3 quarters · filed 2024-02-27 | $79.50M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $21.40M 10-Q · filed 2023-05-09 | $38.20M derived: sum of 2 quarters · filed 2024-02-27 | $54.60M derived: sum of 3 quarters · filed 2024-02-27 | $70.90M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $16.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $33.20M derived: sum of 2 quarters · filed 2024-02-27 | $49.50M derived: sum of 3 quarters · filed 2024-02-27 | $65.90M 10-K · filed 2024-02-27 |
| 2021-09-30 | $16.40M 10-Q · filed 2022-11-07 | $32.70M derived: sum of 2 quarters · filed 2022-11-07 | $49.10M 10-Q · filed 2022-11-07 | $64.70M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $16.30M 10-Q · filed 2022-08-09 | $32.70M 10-Q · filed 2022-08-09 | $48.30M derived: sum of 3 quarters · filed 2023-02-27 | $63.90M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $16.30M 10-Q · filed 2022-05-09 | $32.00M derived: sum of 2 quarters · filed 2023-02-27 | $47.60M derived: sum of 3 quarters · filed 2023-02-27 | $63.40M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $15.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $31.30M derived: sum of 2 quarters · filed 2023-02-27 | $47.10M derived: sum of 3 quarters · filed 2023-02-27 | $62.40M 10-K · filed 2023-02-27 |
| 2020-09-30 | $15.60M 10-Q · filed 2021-11-05 | $31.40M derived: sum of 2 quarters · filed 2021-11-05 | $46.70M 10-Q · filed 2021-11-05 | $61.30M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $15.80M 10-Q · filed 2021-08-04 | $31.00M 10-Q · filed 2021-08-04 | $45.70M derived: sum of 3 quarters · filed 2022-02-25 | $60.50M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $15.20M 10-Q · filed 2020-05-08 | $29.90M derived: sum of 2 quarters · filed 2022-02-25 | $44.70M derived: sum of 3 quarters · filed 2022-02-25 | $59.40M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $14.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $29.50M derived: sum of 2 quarters · filed 2022-02-25 | $44.20M derived: sum of 3 quarters · filed 2022-02-25 | $59.30M 10-K · filed 2022-02-25 |
| 2019-09-30 | $14.80M 10-Q · filed 2020-11-06 | $29.50M derived: sum of 2 quarters · filed 2020-11-06 | $44.60M 10-Q · filed 2020-11-06 | $59.90M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $14.70M 10-Q · filed 2020-08-10 | $29.80M 10-Q · filed 2020-08-10 | $45.10M derived: sum of 3 quarters · filed 2021-02-26 | $60.20M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $15.10M 10-Q · filed 2020-05-08 | $30.40M derived: sum of 2 quarters · filed 2021-02-26 | $45.50M derived: sum of 3 quarters · filed 2021-02-26 | $59.10M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $15.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $30.40M derived: sum of 2 quarters · filed 2021-02-26 | $44.00M derived: sum of 3 quarters · filed 2021-02-26 | $58.10M 10-K · filed 2021-02-26 |
| 2018-09-30 | $15.10M 10-Q · filed 2019-11-12 | $28.70M derived: sum of 2 quarters · filed 2019-11-12 | $42.80M 10-Q · filed 2019-11-12 | $57.90M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $13.60M 10-Q · filed 2019-08-09 | $27.80M 10-Q · filed 2019-08-09 | $42.80M derived: sum of 3 quarters · filed 2020-03-02 | $56.80M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $14.20M 10-Q · filed 2019-05-10 | $29.20M derived: sum of 2 quarters · filed 2020-03-02 | $43.20M derived: sum of 3 quarters · filed 2020-03-02 | $57.60M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $29.00M derived: sum of 2 quarters · filed 2020-03-02 | $43.40M derived: sum of 3 quarters · filed 2020-03-02 | $51.60M 10-K · filed 2020-03-02 |
| 2017-09-30 | $14.00M 10-Q · filed 2018-11-09 | $28.40M derived: sum of 2 quarters · filed 2018-11-09 | $36.60M 10-Q · filed 2018-11-09 | $40.60M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $14.40M 10-Q · filed 2018-08-09 | $22.60M 10-Q · filed 2018-08-09 | $26.60M derived: sum of 3 quarters · filed 2019-03-01 | $30.60M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $8.20M 10-Q · filed 2018-05-10 | $12.20M derived: sum of 2 quarters · filed 2019-03-01 | $16.20M derived: sum of 3 quarters · filed 2019-03-01 | |
| 2016-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $8.00M derived: sum of 2 quarters · filed 2019-03-01 | $16.30M 10-K · filed 2019-03-01 | |
| 2016-09-30 | $4.00M 10-Q · filed 2017-11-09 | $12.30M 10-Q · filed 2017-11-09 | ||
| 2015-12-31 | $15.90M 10-K · filed 2018-03-16 | |||
| 2014-12-31 | $17.00M 10-K · filed 2017-03-01 | |||
| 2013-12-31 | $17.00M 10-K · filed 2016-02-26 | |||
| 2012-12-31 | $16.40M 10-K · filed 2015-02-20 | |||
| 2011-12-31 | $15.60M 10-K · filed 2014-02-21 | |||
| 2010-12-31 | $14.60M 10-K · filed 2013-02-26 | |||
| 2009-12-31 | $13.40M 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |